NCT05627245 2026-03-18Testing the Safety of the Anti-cancer Drugs Tazemetostat and Belinostat in Patients With Lymphomas That Have Resisted TreatmentNational Cancer Institute (NCI)Phase 1 Active not recruiting48 enrolled
NCT06712810 2025-10-10Q702 for the Treatment of Patients With Hematologic MalignanciesMayo ClinicPhase 1 Recruiting46 enrolled
NCT00562380 2013-07-18AMG-479 in Treating Patients With Advanced Solid Tumors or Non-Hodgkin LymphomaNational Cancer Institute (NCI)Phase 1 Completed64 enrolled